Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate

被引:139
作者
Andronesi, Ovidiu C. [1 ]
Rapalino, Otto [2 ]
Gerstner, Elizabeth [3 ,4 ]
Chi, Andrew [3 ,4 ]
Batchelor, Tracy T. [3 ,4 ,5 ]
Cahil, Dan P. [6 ]
Sorensen, A. Gregory [7 ]
Rosen, Bruce R. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Neurooncol, Boston, MA USA
[5] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA USA
[6] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA USA
[7] Siemens Healthcare USA, Malvern, PA USA
关键词
ACUTE MYELOID-LEUKEMIA; ONCOMETABOLITE; 2-HYDROXYGLUTARATE; BRAIN-TUMORS; METABOLIC PROFILES; MR SPECTROSCOPY; SUFFICIENT; BIOMARKER; INSIGHTS; PULSES; ACID;
D O I
10.1172/JCI67229
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
The investigation of metabolic pathways disturbed in isocitrate dehydrogenase (IDH) mutant tumors revealed that the hallmark metabolic alteration is the production of D-2-hydroxyglutarate (D-2HG). The biological impact of D-2HG strongly suggests that high levels of this metabolite may play a central role in propagating downstream the effects of mutant IDH, leading to malignant transformation of cells. Hence, D-2HG may be an ideal biomarker for both diagnosing and monitoring treatment response targeting IDH mutations. Magnetic resonance spectroscopy (MRS) is well suited to the task of noninvasive D-2HG detection, and there has been much interest in developing such methods. Here, we review recent efforts to translate methodology using MRS to reliably measure in vivo D-2HG into clinical research.
引用
收藏
页码:3659 / 3663
页数:5
相关论文
共 62 条
[1]
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours [J].
Amary, M. Fernanda ;
Bacsi, Krisztian ;
Maggiani, Francesca ;
Damato, Stephen ;
Halai, Dina ;
Berisha, Fitim ;
Pollock, Robin ;
O'Donnell, Paul ;
Grigoriadis, Anita ;
Diss, Tim ;
Eskandarpour, Malihe ;
Presneau, Nadege ;
Hogendoorn, Pancras C. W. ;
Futreal, Andrew ;
Tirabosco, Roberto ;
Flanagan, Adrienne M. .
JOURNAL OF PATHOLOGY, 2011, 224 (03) :334-343
[2]
Solid-state NMR adiabatic TOBSY sequences provide enhanced sensitivity for multidimensional high-resolution magic-angle-spinning 1H MR spectroscopy [J].
Andronesi, Ovidiu C. ;
Mintzopoulos, Dionyssios ;
Struppe, Jochem ;
Black, Peter M. ;
Tzika, A. Aria .
JOURNAL OF MAGNETIC RESONANCE, 2008, 193 (02) :251-258
[3]
Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy [J].
Andronesi, Ovidiu C. ;
Kim, Grace S. ;
Gerstner, Elizabeth ;
Batchelor, Tracy ;
Tzika, Aria A. ;
Fantin, Valeria R. ;
Vander Heiden, Matthew G. ;
Sorensen, A. Gregory .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (116)
[4]
Low-Power Adiabatic Sequences for In Vivo Localized Two-Dimensional Chemical Shift Correlated MR Spectroscopy [J].
Andronesi, Ovidiu C. ;
Ramadan, Saadallah ;
Mountford, Carolyn E. ;
Sorensen, A. Gregory .
MAGNETIC RESONANCE IN MEDICINE, 2010, 64 (06) :1542-1556
[5]
Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners [J].
Andronesi, Ovidiu C. ;
Ramadan, Saadallah ;
Ratai, Eva-Maria ;
Jennings, Dominique ;
Mountford, Carolyn E. ;
Sorensen, A. Gregory .
JOURNAL OF MAGNETIC RESONANCE, 2010, 203 (02) :283-293
[6]
[Anonymous], 1990, Principles of Nuclear Magnetic Resonance in One and Two Dimensions
[7]
1H and 13C NMR study of 2-hydroxyglutaric acid and its lactone [J].
Bal, D ;
Gryff-Keller, A .
MAGNETIC RESONANCE IN CHEMISTRY, 2002, 40 (08) :533-536
[8]
High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues [J].
Beckonert, Olaf ;
Coen, Muireann ;
Keun, Hector C. ;
Wang, Yulan ;
Ebbels, Timothy M. D. ;
Holmes, Elaine ;
Lindon, John C. ;
Nicholson, Jeremy K. .
NATURE PROTOCOLS, 2010, 5 (06) :1019-1032
[9]
The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma [J].
Bleeker, Fonnet E. ;
Atai, Nadia A. ;
Lamba, Simona ;
Jonker, Ard ;
Rijkeboer, Denise ;
Bosch, Klazien S. ;
Tigchelaar, Wikky ;
Troost, Dirk ;
Vandertop, W. Peter ;
Bardelli, Alberto ;
Van Noorden, Cornelis J. F. .
ACTA NEUROPATHOLOGICA, 2010, 119 (04) :487-494
[10]
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping [J].
Borger, Darrell R. ;
Tanabe, Kenneth K. ;
Fan, Kenneth C. ;
Lopez, Hector U. ;
Fantin, Valeria R. ;
Straley, Kimberly S. ;
Schenkein, David P. ;
Hezel, Aram F. ;
Ancukiewicz, Marek ;
Liebman, Hannah M. ;
Kwak, Eunice L. ;
Clark, Jeffrey W. ;
Ryan, David P. ;
Deshpande, Vikram ;
Dias-Santagata, Dora ;
Ellisen, Leif W. ;
Zhu, Andrew X. ;
Iafrate, A. John .
ONCOLOGIST, 2012, 17 (01) :72-79